Overview
Familial isolated congenital asplenia (FICA), also known as isolated congenital asplenia or hereditary splenic agenesis, is an extremely rare condition characterized by the complete absence of the spleen from birth without any other associated developmental abnormalities. Unlike asplenia that occurs as part of heterotaxy syndromes (where the arrangement of internal organs is disrupted), familial isolated congenital asplenia occurs as an isolated finding, meaning the heart and other organs develop normally. The condition primarily affects the immune system, as the spleen plays a critical role in filtering blood and mounting immune responses against encapsulated bacteria. Patients with FICA are at severely increased risk of life-threatening, overwhelming bacterial infections (known as overwhelming post-splenectomy infection or OPSI-like sepsis), particularly from encapsulated organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. These fulminant infections can occur at any age but are especially dangerous in infancy and early childhood, and they carry a high mortality rate if not promptly recognized and treated. The condition may go undiagnosed until a severe septic episode occurs, as the absence of the spleen may not cause obvious symptoms otherwise. Characteristic blood smear findings include Howell-Jolly bodies (nuclear remnants in red blood cells that are normally removed by the spleen). Management of familial isolated congenital asplenia focuses on infection prevention and includes lifelong prophylactic antibiotics (typically penicillin, especially in childhood), comprehensive vaccination against encapsulated bacteria (pneumococcal, meningococcal, and Haemophilus influenzae type b vaccines), and prompt empiric antibiotic treatment for any febrile illness. Patient and family education about the risks of infection is essential. Mutations in the RPSA gene (encoding ribosomal protein SA) have been identified as a cause of this condition in multiple families. Genetic counseling is recommended for affected families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Familial isolated congenital asplenia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial isolated congenital asplenia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial isolated congenital asplenia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Familial isolated congenital asplenia.
Community
No community posts yet. Be the first to share your experience with Familial isolated congenital asplenia.
Start the conversation →Latest news about Familial isolated congenital asplenia
No recent news articles for Familial isolated congenital asplenia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial isolated congenital asplenia
What is Familial isolated congenital asplenia?
Familial isolated congenital asplenia (FICA), also known as isolated congenital asplenia or hereditary splenic agenesis, is an extremely rare condition characterized by the complete absence of the spleen from birth without any other associated developmental abnormalities. Unlike asplenia that occurs as part of heterotaxy syndromes (where the arrangement of internal organs is disrupted), familial isolated congenital asplenia occurs as an isolated finding, meaning the heart and other organs develop normally. The condition primarily affects the immune system, as the spleen plays a critical role i
How is Familial isolated congenital asplenia inherited?
Familial isolated congenital asplenia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Familial isolated congenital asplenia typically begin?
Typical onset of Familial isolated congenital asplenia is neonatal. Age of onset can vary across affected individuals.